Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: Cost effectiveness analysis based on a Dutch microsimulation model

2012-03-10

Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings

Cost effectiveness analysis based on a Dutch microsimulation model

[to follow]

Additional Metadata
Persistent URL	doi.org/10.1136/bmj.e670, hdl.handle.net/1765/31582
Journal	BMJ British medical journal
Note	The following files are available in addition to the article: Calculation tool [deki8744693.ww2.xlsx]. Graphic representation of screening strategies [deki874693.wf1]. Efficient frontier ... etc. [deki874693.wf2]. Description of MISCAN-cervix mode [deki874693.ww1]
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	de Kok, I., van Rosmalen, J., Dillner, J., Arbyn, M., Sasieni, P.& van Ballegooijen, M. (2012). Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: Cost effectiveness analysis based on a Dutch microsimulation model. BMJ British Medical Journal, 2012.https://doi.org/10.1136/bmj.e670